Sign In
Buy RXST
$6.01
-0.0700 (-1.15%)
At Close: Jul 31, 2026
RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
04:10pm, Wednesday, 11'th Feb 2026
ALISO VIEJO, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
Head to Head Analysis: RxSight (NASDAQ:RXST) vs. Edap Tms (NASDAQ:EDAP)
01:56am, Monday, 09'th Feb 2026
Edap Tms (NASDAQ: EDAP - Get Free Report) and RxSight (NASDAQ: RXST - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses ba
Baillie Gifford & Co. Raises Stock Holdings in RxSight, Inc. $RXST
03:36am, Monday, 26'th Jan 2026
Baillie Gifford and Co. boosted its stake in shares of RxSight, Inc. (NASDAQ: RXST) by 46.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities a
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of “Reduce” by Analysts
02:22am, Monday, 26'th Jan 2026
RxSight, Inc. (NASDAQ: RXST - Get Free Report) has received a consensus rating of "Reduce" from the thirteen ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment ana
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
10:00am, Thursday, 22'nd Jan 2026
NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to co
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
04:17pm, Tuesday, 20'th Jan 2026
NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are advise
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
10:00am, Thursday, 15'th Jan 2026
NEW YORK, Jan. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to con
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
09:45pm, Tuesday, 13'th Jan 2026
RxSight, Inc. (RXST) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
04:23pm, Tuesday, 13'th Jan 2026
NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are advise
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
07:20am, Tuesday, 13'th Jan 2026
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer
09:30am, Sunday, 11'th Jan 2026
ALISO VIEJO, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
10:00am, Thursday, 08'th Jan 2026
NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to cont
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
11:40am, Tuesday, 06'th Jan 2026
NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST). Such investors are ad
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
04:05pm, Friday, 02'nd Jan 2026
ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST
10:00am, Thursday, 01'st Jan 2026
NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RxSight, Inc. ("RxSight" or the "Company") (NASDAQ: RXST). Such investors are advised to cont
